Exploring Efficacy and Safety in Giant-Cell Arteritis Treatments

This chapter explores the treatment options for CNS vasculitis, highlighting the anticipated results of a phase 3 trial of upadacitinib for giant-cell arteritis. The discussion emphasizes the critical evaluation of switching patients from upadacitinib to placebo and compares these outcomes with standard steroid treatments.